Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

In this setting a reevaluation of the patient and the COPD treatment regimen should be undertaken at once. Increasing the daily dose of umeclidinium beyond the recommended dose is not appropriate ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Furthermore, it is of great importance to understand the mechanisms behind the therapy in order to further strengthen the protective effect of ECP -- based on this, an optimal treatment regimen ...